FDA Efforts For Faster Approval Of Generic Drugs
Submitted by sai on Tue, 11/27/2007 - 14:53.
There's a huge backlog at the FDA's OGD, which has seen the number of submitted applications increase by 150 percent
According to the FDA, fewer generics are being approved for two reasons:
A shortage of personnel
and the number of faulty applications that generic companies submit.
OGD needs up to 100 more employees over the next three years to eliminate the build up--a move that would cost between $16 million and $19 million a year.
More funding to the Office of Generic Drugs (OGD) seems to be more logical option to improve adminstrative efficiencies.
